DRUG

GlcNAc

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for GlcNAc

Inflammatory bowel disease 1

Mediator Outcome Score Tier Lit. status Trial
IL-17 Crohn's disease 0.208 Mid partial evidence preclinical only

Clinical trials

6 registered trials for GlcNAc

Source: ClinicalTrials.gov

← All drugs